118 related articles for article (PubMed ID: 8294704)
1. Prevention of arterial thrombosis by a monoclonal antibody against the 100 to 109 amino acid sequence stretch of the beta-subunit of the human platelet fibrinogen receptor: a comparative study with low dose aspirin.
Escudero C; Alvarez L; de Haro J; González J; Alvarez MV; Millán I; Jorge-Herrero E; Castillo-Olivares JL
J Am Coll Cardiol; 1994 Feb; 23(2):483-6. PubMed ID: 8294704
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic effects of a platelet fibrinogen receptor antagonist in a canine model of carotid artery thrombosis.
Willette RN; Sauermelch CF; Rycyna R; Sarkar S; Feuerstein GZ; Nichols AJ; Ohlstein EH
Stroke; 1992 May; 23(5):703-11. PubMed ID: 1605806
[TBL] [Abstract][Full Text] [Related]
3. Prevention of reoccluding platelet-rich thrombi in canine femoral arteries with a novel peptide antagonist of platelet glycoprotein IIb/IIIa receptors.
Haskel EJ; Adams SP; Feigen LP; Saffitz JE; Gorczynski RJ; Sobel BE; Abendschein DR
Circulation; 1989 Dec; 80(6):1775-82. PubMed ID: 2513145
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
Mousa SA; Bozarth JM; Forsythe MS; Jackson SM; Leamy A; Diemer MM; Kapil RP; Knabb RM; Mayo MC; Pierce SK
Circulation; 1994 Jan; 89(1):3-12. PubMed ID: 8281661
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic effects of DMP 728, a platelet GPIIb/IIIa receptor antagonist, in a canine model of arterial thrombosis.
Rote WE; Davis JH; Mousa SA; Reilly TM; Lucchesi BR
J Cardiovasc Pharmacol; 1994 Apr; 23(4):681-9. PubMed ID: 7516023
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody against the platelet glycoprotein IIb/IIIa receptor complex prevents platelet aggregation and thrombosis in a canine model of coronary angioplasty.
Bates ER; McGillem MJ; Mickelson JK; Pitt B; Mancini GB
Circulation; 1991 Dec; 84(6):2463-9. PubMed ID: 1659954
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic map of the N-terminal domain of the GPIIIa subunit of the human platelet fibrinogen receptor (GPIIb-IIIa) determined in vivo by monoclonal, immunochemical inhibition of acute arterial thrombosis.
Escudero C; Alvarez MV; de Haro J; Alvarez L; Millán I; Castillo-Olivares JL; González-Rodríguez J
Platelets; 1997; 8(5):349-54. PubMed ID: 16793667
[TBL] [Abstract][Full Text] [Related]
8. Prevention of the formation of arterial thrombi using different antiplatelet drugs: experimental study in dogs.
Escudero-Vela MC; Alvarez L; Rodríguez V; del Moral JH; Millán I; Castillo-Olivares JL
Thromb Res; 1989 May; 54(3):187-95. PubMed ID: 2749611
[TBL] [Abstract][Full Text] [Related]
9. Interruption of vascular thrombosis by bolus anti-platelet glycoprotein IIb/IIIa monoclonal antibodies in baboons.
Krupski WC; Bass A; Kelly AB; Ruggeri ZM; Harker LA; Hanson SR
J Vasc Surg; 1993 Feb; 17(2):294-303; discussion 303-4. PubMed ID: 8433425
[TBL] [Abstract][Full Text] [Related]
10. Platelet GPIIb/IIIa receptor inhibition by SC-49992 prevents thrombosis and rethrombosis in the canine carotid artery.
Rote WE; Werns SW; Davis JH; Feigen LP; Kilgore KS; Lucchesi BR
Cardiovasc Res; 1993 Mar; 27(3):500-7. PubMed ID: 8490951
[TBL] [Abstract][Full Text] [Related]
11. Effects of GP IIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosis.
Makkar RR; Litvack F; Eigler NL; Nakamura M; Ivey PA; Forrester JS; Shah PK; Jordan RE; Kaul S
Circulation; 1997 Feb; 95(4):1015-21. PubMed ID: 9054765
[TBL] [Abstract][Full Text] [Related]
12. Roles of thrombin and platelet membrane glycoprotein IIb/IIIa in platelet-subendothelial deposition after angioplasty in an ex vivo whole artery model.
Kaplan AV; Leung LL; Leung WH; Grant GW; McDougall IR; Fischell TA
Circulation; 1991 Sep; 84(3):1279-88. PubMed ID: 1832095
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody-induced inhibition of platelet function: effects on hemostasis and vascular graft thrombosis in baboons.
Torem S; Schneider PA; Hanson SR
J Vasc Surg; 1988 Jan; 7(1):172-80. PubMed ID: 3336123
[TBL] [Abstract][Full Text] [Related]
14. Time course of the effects of a single bolus injection of F(ab')2 fragments of the antiplatelet GPIIb/IIIa antibody 7E3 on arterial eversion graft occlusion, platelet aggregation, and bleeding time in dogs.
Kiss RG; Lu HR; Roskams T; Jang IK; Plow EF; Gold HK; Collen D
Arterioscler Thromb; 1994 Mar; 14(3):367-74. PubMed ID: 8123640
[TBL] [Abstract][Full Text] [Related]
15. High dose intravenous aspirin, not low dose intravenous or oral aspirin, inhibits thrombus formation and stabilizes blood flow in experimental coronary vascular injury.
Mickelson JK; Hoff PT; Homeister JW; Fantone JC; Lucchesi BR
J Am Coll Cardiol; 1993 Feb; 21(2):502-10. PubMed ID: 8426017
[TBL] [Abstract][Full Text] [Related]
16. [Use of aspirin in the primary prevention of vascular thrombi. A comparative study with other anti-aggregant drugs].
Escudero MC; Alvarez L; Rodríguez V; de Haro J; Millán I; Castillo-Olivares JL
Rev Esp Cardiol; 1989 Oct; 42(8):536-40. PubMed ID: 2602610
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation.
Yasuda T; Gold HK; Yaoita H; Leinbach RC; Guerrero JL; Jang IK; Holt R; Fallon JT; Collen D
J Am Coll Cardiol; 1990 Sep; 16(3):714-22. PubMed ID: 2117620
[TBL] [Abstract][Full Text] [Related]
18. Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon.
Hanson SR; Pareti FI; Ruggeri ZM; Marzec UM; Kunicki TJ; Montgomery RR; Zimmerman TS; Harker LA
J Clin Invest; 1988 Jan; 81(1):149-58. PubMed ID: 2961790
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
20. Prevention of thrombosis and rethrombosis and enhancement of the thrombolytic actions of recombinant tissue-type plasminogen activator in the canine heart by DMP728, a glycoprotein IIb/IIIa antagonist.
Lucchessi BR; Rote WE; Driscoll EM; Mu DX
Br J Pharmacol; 1994 Dec; 113(4):1333-43. PubMed ID: 7889289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
